STS Medical receives FDA regulatory clearance
STS Medical Ltd. has announced that it received regulatory clearance from the FDA for its composite sinus stent. Millions of people worldwide suffer from chronic sinusitis, an inflammation of the sinuses caused by infection or allergy and characterised by facial pain and pressure, nasal congestion, and headaches. When drug treatments are ineffective, Functional Endoscopic Sinus Surgery (FESS) is often performed to increase airflow within the...
Induced pluripotent stem cells grow functioning human muscle
Biomedical engineers have grown the first functioning human skeletal muscle from induced pluripotent stem cells. The advance builds on work published in 2015 when researchers at Duke University grew the first functioning human muscle tissue from cells obtained from muscle biopsies.
Technology develops brain wiring diagrams
The human brain is composed of billions of neurons wired together in intricate webs and communicating through electrical pulses and chemical signals. Although neuroscientists have made progress in understanding the brain's many functions—such as regulating sleep, storing memories, and making decisions—visualising the entire "wiring diagram" of neural connections throughout a brain is not possible using currently available methods.
App transports the care industry into the digital age
The introduction of a new app, KareInn, is set to bring the caregiving industry into the digital age. With public spending on social care falling by up to 30% since 2010, there is a desperate need for care homes to provide better quality care in a more cost-efficient way. KareInn enables carers to spend more time caring and provide a better quality of care.
Supercharged antibiotics could fight superbugs
A drug supercharged by University of Queensland researchers has emerged as a new antibiotic that could destroy some of the world’s most dangerous superbugs. The supercharge technique , led by Dr Mark Blaskovich and Professor Matt Cooper from UQ’s IMB, potentially could revitalise other antibiotics. Antibiotic-resistant bacteria – superbugs – cause 700,000 deaths worldwide each year, and a UK government review has...
Dermapace System receives FDA Approval
SANUWAVE Health, Inc. has announced that the FDA has issued its decision on the de novo submission for the dermaPACE System. Their decision, dated December 28, 2017, permits the marketing of the dermaPACE System as a Class II medical device used for the treatment of Diabetic Foot Ulcers (DFU) in the U.S., the world’s largest medical device market.
Eye disease could be treated with stem cells
Scientists at the National Eye Institute (NEI), part of the National Institutes of Health, report that tiny tube-like protrusions called primary cilia on cells of the retinal pigment epithelium (RPE) - a layer of cells in the back of the eye - are essential for the survival of the retina's light-sensing photoreceptors.
Micro-robots made from algae could aid treatment
In tests, a swarm of robots measuring a few millionths of a metre long – about the size of a blood cell – were guided magnetically to sites in the stomach of rats. The robots were manufactured by coating tiny algae with magnetic particles. They could be tracked in tissue close to the skin’s surface by imaging the algae’s natural fluorescence, and in hard-to-reach deeper tissue by magnetic resonance imaging (MRI).
Artificial bacteria reflect signals for ultrasound imaging
In the 1966 science fiction film Fantastic Voyage, a submarine is shrunken down and injected into a scientist's body to repair a blood clot in his brain. While the movie may be still be fiction, researchers at Caltech are making strides in this direction: they have, for the first time, created bacterial cells with the ability to reflect sound waves from inside bodies, reminiscent of how submarines reflect sonar to reveal their locations.
Spider's web inspires removable implant for managing type 1 diabetes
For the more than 1 million Americans who live with type 1 diabetes, daily insulin injections are literally a matter of life and death. And while there is no cure, a Cornell University-led research team has developed a device that could revolutionise management of the disease.